服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-B7H3/CD276 mAbs [Omburtamab Biosimilar] (MABL-5022) | MABL-5022 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CLDN18 mAbs [Omectatug Biosimilar] (MABL-5023) | MABL-5023 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C5 mAbs [Omoprubart Biosimilar] (MABL-5024) | MABL-5024 | ELISA, FACS, Functional assay, in vivo binding | G2/G4, Kappa |
| Anti-Staphylococcus aureus Protein A mAbs [Omodenbamab Biosimilar] (MABL-5025) | MABL-5025 | ELISA, FACS, Functional assay, in vivo binding | G3, Kappa |
| Anti-IL13;IL4 mAbs [Ompekimig1 Biosimilar] (MABL-5026) | MABL-5026 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Kappa |
| Anti-IL33 mAbs [Ompekimig2 Biosimilar] (MABL-5027) | MABL-5027 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MET/HGFR mAbs [Onartuzumab Biosimilar] (MABL-5028) | MABL-5028 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FN extracellular domain B mAbs [Onfekafusp Biosimilar] (MABL-5029) | MABL-5029 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-PCSK9 mAbs [Ongericimab Biosimilar] (MABL-5030) | MABL-5030 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-MADCAM1 mAbs [Ontamalimab Biosimilar] (MABL-5031) | MABL-5031 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-CD248/CD164L1 mAbs [Ontuxizumab Biosimilar] (MABL-5032) | MABL-5032 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VSIR/VISTA/B7H5/PD1H/SISP1 mAbs [Onvatilimab Biosimilar] (MABL-5033) | MABL-5033 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MS4A1/CD20 mAbs [Obinutuzumab Biosimilar] (MABL-5003) | MABL-5003 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-B7H3/CD276;CD3E mAbs [Obrindatamab Biosimilar] (MABL-5004) | MABL-5004 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda |
| Anti-DLL3;CD3E mAbs [Obrixtamig Biosimilar] (MABL-5005) | MABL-5005 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-TSLP mAbs [Ocankitug Biosimilar] (MABL-5006) | MABL-5006 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MS4A1/CD20 mAbs [Ocaratuzumab Biosimilar] (MABL-5007) | MABL-5007 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Ociperlimab Biosimilar] (MABL-5008) | MABL-5008 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MS4A1/CD20 mAbs [Ocrelizumab Biosimilar] (MABL-5009) | MABL-5009 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Zaire Ebolavirus Glycoprotein mAbs [Odesivimab Biosimilar] (MABL-5010) | MABL-5010 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn